Example: Heart Attack

Search clinical trials for: Procarbazine

Total 76 results

NCT01737346

Unknown status

Procarbazine and Lomustine in Recurrent Glioblastoma

Conditions: Recurrent Glioblastoma Multiforme
NCT00003564

Withdrawn

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Conditions: Brain and Central Nervous System Tumors
NCT02800447

Unknown status

Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol

Conditions: Advanced Hodgkin's Lymphoma
NCT00004004

Completed

Procarbazine in Treating Patients With Recurrent Brain Tumor

Conditions: Brain and Central Nervous System Tumors
NCT00596154

Active, not recruiting

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Conditions: CNS Lymphoma; CNS Brain Cancer; Non-Hodgkin's Lymphoma
NCT00503594

Unknown status

Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine

Conditions: Lymphoma
NCT01124240

Unknown status

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene

Conditions: Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
NCT00079092

Completed

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00003293

Completed

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
NCT01399372

Active, not recruiting

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Conditions: Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Lymphoma; Neurotoxicity; Radiation Toxicity
NCT00074191

Completed

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Conditions: Lymphoma
NCT00002463

Completed

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Conditions: Brain and Central Nervous System Tumors
NCT02333513

Unknown status

A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

Conditions: Recurrent High-grade Glioma
NCT03576378

Active, not recruiting

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Conditions: Hodgkin Lymphoma
NCT00002840

Completed

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Conditions: Brain and Central Nervous System Tumors
NCT00052455

Completed

Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00002806

Completed

Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma

Conditions: Brain and Central Nervous System Tumors
NCT04446962

Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Conditions: Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary
NCT00079105

Completed

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

Conditions: Lymphoma
NCT00594815

Completed

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Conditions: Lymphoma
NCT00887146

Recruiting

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Conditions: Brain and Central Nervous System Tumors
NCT01130194

Completed

Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma

Conditions: Follicular Lymphoma
NCT00151281

Completed

Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma

Conditions: Non-Hodgkin's Lymphoma
NCT00005796

Completed

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Conditions: Bone Marrow Suppression; Brain and Central Nervous System Tumors; Drug/Agent Toxicity by Tissue/Organ
NCT03495960

Recruiting

Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Conditions: Primary Central Nervous System Lymphoma